tiprankstipranks
Trending News
More News >
Foghorn Therapeutics initiated with an Outperform at Citizens JMP
PremiumThe FlyFoghorn Therapeutics initiated with an Outperform at Citizens JMP
11d ago
Promising Advancements and Strategic Collaborations Position Foghorn Therapeutics as a Strong Buy
Premium
Ratings
Promising Advancements and Strategic Collaborations Position Foghorn Therapeutics as a Strong Buy
2M ago
Promising Potential of Foghorn Therapeutics’ FHD-909 Drives Buy Rating Amid Strategic Advances
Premium
Ratings
Promising Potential of Foghorn Therapeutics’ FHD-909 Drives Buy Rating Amid Strategic Advances
2M ago
Foghorn Therapeutics Advances Drug Development in Oncology
PremiumCompany AnnouncementsFoghorn Therapeutics Advances Drug Development in Oncology
3M ago
Foghorn Therapeutics initiated with a Buy at B. Riley
Premium
The Fly
Foghorn Therapeutics initiated with a Buy at B. Riley
3M ago
Foghorn Therapeutics files $300M mixed securities shelf
Premium
The Fly
Foghorn Therapeutics files $300M mixed securities shelf
3M ago
Foghorn Therapeutics price target lowered to $13 from $20 at H.C. Wainwright
PremiumThe FlyFoghorn Therapeutics price target lowered to $13 from $20 at H.C. Wainwright
5M ago
Foghorn Therapeutics price target lowered to $14 from $18 at Jefferies
Premium
The Fly
Foghorn Therapeutics price target lowered to $14 from $18 at Jefferies
5M ago
Foghorn Therapeutics Advances Precision Oncology Pipeline
Premium
Company Announcements
Foghorn Therapeutics Advances Precision Oncology Pipeline
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100